Fezolinetant
Cross-source consensus on Fezolinetant from 1 sources and 4 claims.
1 sources · 4 claims
Uses
How it works
Benefits
Risks & contraindications
Highlighted claims
- Fezolinetant requires liver enzyme monitoring at 3, 6, and 9 months after initiation due to risk of hepatic injury. — Menopause Hormone Therapy: Updated Evidence, Risk Reassessment, and Clinical Guidance
- Fezolinetant acts on the hypothalamus to block the NK3 receptor signaling pathway that triggers vasomotor symptoms. — Menopause Hormone Therapy: Updated Evidence, Risk Reassessment, and Clinical Guidance
- Fezolinetant is an appropriate option for women who cannot or choose not to use hormone therapy. — Menopause Hormone Therapy: Updated Evidence, Risk Reassessment, and Clinical Guidance
- Fezolinetant reduces hot flash frequency by approximately 60%, exceeding the effectiveness of antidepressants. — Menopause Hormone Therapy: Updated Evidence, Risk Reassessment, and Clinical Guidance